trending Market Intelligence /marketintelligence/en/news-insights/trending/hmvxsvudrtumpuekd73yug2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Chembio Diagnostics appoints director

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

Blog

Corporate Credit Risk Trends in Developing Markets: A Probability of Default Perspective


Chembio Diagnostics appoints director

Chembio Diagnostics Inc. appointed John Potthoff to its board.

Potthoff is the CEO of Elligo Health Research Inc., a clinical research company in Austin, Texas.

Medford, N.Y.-based Chembio Diagnostics develops point-of-care diagnostic tests that are used to detect or monitor diseases.